POLYRIZON LTD (PLRZ) Stock Price & Overview
NASDAQ:PLRZ • IL0011814113
Current stock price
The current stock price of PLRZ is 13.7 USD. Today PLRZ is up by 1.48%. In the past month the price increased by 5.22%. In the past year, price decreased by -98.36%.
PLRZ Key Statistics
- Market Cap
- 21.783M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -807.27
- Dividend Yield
- N/A
PLRZ Stock Performance
PLRZ Stock Chart
PLRZ Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to PLRZ. When comparing the yearly performance of all stocks, PLRZ is a bad performer in the overall market: 86.49% of all stocks are doing better.
PLRZ Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PLRZ. PLRZ has a great financial health rating, but its profitability evaluates not so good.
PLRZ Earnings
PLRZ Forecast & Estimates
PLRZ Groups
Sector & Classification
PLRZ Financial Highlights
Over the last trailing twelve months PLRZ reported a non-GAAP Earnings per Share(EPS) of -807.27. The EPS decreased by -207.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.51% | ||
| ROE | -9.7% | ||
| Debt/Equity | 0 |
PLRZ Ownership
PLRZ Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.82 | 364.65B | ||
| AMGN | AMGEN INC | 15.24 | 188.631B | ||
| GILD | GILEAD SCIENCES INC | 15.52 | 175.177B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.42 | 116.358B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.68 | 77.963B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 41.84 | 41.258B | ||
| INSM | INSMED INC | N/A | 31.039B | ||
| NTRA | NATERA INC | N/A | 28.733B | ||
| BIIB | BIOGEN INC | 11.29 | 26.917B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.55 | 23.098B | ||
| MRNA | MODERNA INC | N/A | 20.683B | ||
| EXAS | EXACT SCIENCES CORP | 345.14 | 19.837B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.676B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PLRZ
Company Profile
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..
Company Info
IPO: 2024-10-29
POLYRIZON LTD
HaTidhar St. 5
Ra'anana IL
Employees: 1
Phone: 97293740120
POLYRIZON LTD / PLRZ FAQ
Can you describe the business of POLYRIZON LTD?
Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..
What is the current price of PLRZ stock?
The current stock price of PLRZ is 13.7 USD. The price increased by 1.48% in the last trading session.
What is the dividend status of POLYRIZON LTD?
PLRZ does not pay a dividend.
How is the ChartMill rating for POLYRIZON LTD?
PLRZ has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the PE ratio for PLRZ stock?
POLYRIZON LTD (PLRZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-807.27).
What is the ownership structure of POLYRIZON LTD (PLRZ)?
You can find the ownership structure of POLYRIZON LTD (PLRZ) on the Ownership tab.